What are the formation and functions of bile salts, bile pigments, urobilinogen, and stercobilin in the digestive process?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Formation and Functions of Bile Salts, Bile Pigments, Urobilinogen, and Stercobilin

Bile salts, bile pigments, urobilinogen, and stercobilin are critical components of the digestive process with specific formation pathways and essential physiological functions.

Bile Salts

Formation

  • Bile salts are synthesized in the liver from cholesterol, then conjugated with glycine or taurine before secretion into bile 1
  • The concentration of bile salts in the small intestine ranges from 3 mM (fasted state) to 20 mM (fed state) 2
  • Common bile salts include sodium glycodeoxycholate, sodium deoxycholate, taurocholate, taurodeoxycholate, cholate, and glycocholate 2
  • Bile salt synthesis is regulated by nuclear receptors including farnesoid X receptor (FXR), which can be activated by bile acids themselves, creating a feedback loop 3

Functions

  • Bile salts are essential for the absorption of lipids and lipophilic components in the digestive tract 2
  • They form micelles with dietary fats, facilitating their digestion and absorption 1
  • Bile salts play a critical role in cholesterol solubility in bile by forming mixed micelles with cholesterol and phospholipids 1
  • They undergo enterohepatic circulation, where 95% are reabsorbed in the terminal ileum and recycled back to the liver, maintaining efficient bile salt secretion 1
  • Bile salts act as signaling molecules that regulate their own synthesis through FXR activation 3

Bile Pigments

Formation

  • Bile pigments primarily consist of bilirubin, which is a breakdown product of heme catabolism 4
  • Heme is first converted to biliverdin by heme oxygenase, then to unconjugated bilirubin by biliverdin reductase 4
  • Unconjugated bilirubin is transported to the liver bound to albumin, where it is conjugated with glucuronic acid by UDP-glucuronosyltransferase to form bilirubin diglucuronide 5
  • Conjugated bilirubin is secreted into bile and transported to the intestine 6

Functions

  • Bile pigments give bile its characteristic yellow-green color 4
  • Recent research suggests bilirubin may function as a metabolic hormone that drives gene transcription by nuclear receptors 4
  • Bilirubin has antioxidant properties and may be protective at mildly elevated levels 4
  • Abnormally low bilirubin levels (hypobilirubinemia) are associated with metabolic dysfunction and cardiovascular complications 4

Urobilinogen

Formation

  • Urobilinogen is formed in the intestine when conjugated bilirubin is hydrolyzed by bacterial β-glucuronidase to release unconjugated bilirubin 5
  • Unconjugated bilirubin is then reduced by intestinal bacteria, particularly Clostridium perfringens, to form colorless urobilinogen 5
  • The reduction process is enzymatically catalyzed and involves the reduction of double bonds in the bilirubin molecule 5

Functions

  • Approximately 10-20% of urobilinogen is reabsorbed from the intestine into the portal circulation 5
  • Most reabsorbed urobilinogen returns to the liver and is re-excreted in bile 5
  • A small portion of urobilinogen enters the systemic circulation and is excreted in urine 5
  • Urobilinogen levels in urine can be used as a diagnostic marker for liver function and hemolytic conditions 5

Stercobilin

Formation

  • Stercobilin is formed from the oxidation of stercobilinogen, which is a further reduction product of urobilinogen 5
  • However, some bacterial strains like C. perfringens do not reduce urobilinogen all the way to stercobilinogen 5
  • The conversion of urobilinogen to stercobilinogen and subsequently to stercobilin occurs in the distal intestine through bacterial action 5

Functions

  • Stercobilin gives feces its characteristic brown color 5
  • It represents the final excretory product of heme metabolism 5
  • Stercobilin is not reabsorbed from the intestine and is completely eliminated in feces 5
  • Changes in stercobilin production can indicate alterations in bile pigment metabolism or intestinal bacterial flora 5

Clinical Significance

  • Disruptions in bile formation and flow can lead to cholestasis, jaundice, pruritus, and liver damage 7
  • Genetic defects in bile transporters can lead to various cholestatic disorders, including Progressive Familial Intrahepatic Cholestasis (PFIC) 7
  • Ursodeoxycholic acid (UDCA) is commonly used to treat cholestatic conditions by changing bile composition from hydrophobic to more hydrophilic 8
  • Abnormal levels of urobilinogen in urine or stercobilin in feces can indicate liver disease, biliary obstruction, or hemolytic disorders 5

References

Research

Bile salt metabolism. I. The physiology of bile salts.

Australian and New Zealand journal of medicine, 1977

Guideline

Bile Composition and Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bilirubin as a metabolic hormone: the physiological relevance of low levels.

American journal of physiology. Endocrinology and metabolism, 2021

Research

Identification of bilirubin reduction products formed by Clostridium perfringens isolated from human neonatal fecal flora.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006

Research

Absorption of bile pigments by the gall bladder.

The Journal of clinical investigation, 1967

Guideline

Bile Transport Mechanisms and Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Liver Disorders with Ursodeoxycholic Acid and Rifaximin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.